These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports. Colombo E; Gurizzan C; Ottini A; Caspani F; Bergamini C; Locati LD; Marchiselli C; Alberti A; Lorini L; Licitra LF; Bossi P; Resteghini C Front Oncol; 2023; 13():1111146. PubMed ID: 36925925 [TBL] [Abstract][Full Text] [Related]
11. Switching Hedgehog inhibitors and other strategies to address resistance when treating advanced basal cell carcinoma. Doan HQ; Chen L; Nawas Z; Lee HH; Silapunt S; Migden M Oncotarget; 2021 Sep; 12(20):2089-2100. PubMed ID: 34611482 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Cemiplimab for the Management of Non-Melanoma Skin Cancer: A Drug Safety Evaluation. Potestio L; Scalvenzi M; Lallas A; Martora F; Guerriero L; Fornaro L; Marano L; Villani A Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730683 [TBL] [Abstract][Full Text] [Related]
13. The current clinical approach to difficult-to-treat basal cell carcinomas. Di Brizzi EV; Argenziano G; Brancaccio G; Scharf C; Ronchi A; Moscarella E Expert Rev Anticancer Ther; 2023 Jan; 23(1):43-56. PubMed ID: 36579630 [TBL] [Abstract][Full Text] [Related]
14. Complete response of advanced cutaneous squamous cell and basal cell carcinomas with sequential cemiplimab and sonidegib therapy. Weis J; Grote C; Weichenthal M; Hauschild A J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():66-69. PubMed ID: 34855253 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study. Dummer R; Guminksi A; Gutzmer R; Lear JT; Lewis KD; Chang ALS; Combemale P; Dirix L; Kaatz M; Kudchadkar R; Loquai C; Plummer R; Schulze HJ; Stratigos AJ; Trefzer U; Squittieri N; Migden MR Br J Dermatol; 2020 Jun; 182(6):1369-1378. PubMed ID: 31545507 [TBL] [Abstract][Full Text] [Related]
16. Brief overview: cemiplimab for the treatment of advanced basal cell carcinoma: PD-1 strikes again. Davis CM; Lewis KD Ther Adv Med Oncol; 2022; 14():17588359211066147. PubMed ID: 35082923 [TBL] [Abstract][Full Text] [Related]
17. Primary basosquamous carcinoma of the lower eyelid with ocular invasion A case report. Papadopoulos GO; Charitonidi E; Filippou N; Fanidou D; Filippou D; Scandalakis P Ann Ital Chir; 2018 Mar; 7():. PubMed ID: 29626183 [TBL] [Abstract][Full Text] [Related]